Stocks · US
GMED
XNYS
GLOBUS MEDICAL INC
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E19.20x
P/B2.16x
P/S3.27x
EPS$3.99
ROE11.23%
ROA9.76%
Dividend yield0.00%
EV/EBITDA10.25x
Debt/Equity0.00
Free cash flow$756M
Returns and 52-week range
1W+0.98%
1M-2.38%
3M+0.30%
6M-15.08%
1Y+26.37%
YTD-12.45%
52W high$101.40
52W low$56.50
From 52W high-24.62%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 유니버설 헬스 서비시스 | $10.4B | 6.80 | 1.38 | +4.38% |
| Bio-Rad Laboratories, Inc.Class A | $10.2B | 45.66 | 1.42 | -4.48% |
| Avantor, Inc. | $10.7B | — | 1.90 | +3.07% |
| 몰리나 헬스케어 | $10.1B | — | 2.43 | -2.80% |
| Repligen Corp | $10.7B | 257.46 | 5.06 | +4.33% |
| The Ensign Group, Inc. | $10.1B | 26.61 | 4.13 | +0.74% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.